Amedisys Return on Tangible Equity 2010-2025 | AMED

Current and historical return on tangible equity values for Amedisys (AMED) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Amedisys Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.09B $-0.05B -75.79%
2024-12-31 $0.04B $-0.12B -27.30%
2024-09-30 $0.08B $-0.14B -44.15%
2024-06-30 $0.09B $-0.17B -42.62%
2024-03-31 $-0.02B $-0.20B 8.61%
2023-12-31 $-0.01B $-0.23B 4.07%
2023-09-30 $0.00B $-0.26B -1.16%
2023-06-30 $0.00B $-0.29B -1.09%
2023-03-31 $0.11B $-0.21B -38.63%
2022-12-31 $0.12B $-0.28B -38.40%
2022-09-30 $0.12B $-0.32B -37.57%
2022-06-30 $0.14B $-0.36B -42.22%
2022-03-31 $0.19B $-0.29B -69.08%
2021-12-31 $0.21B $-0.33B -81.32%
2021-09-30 $0.22B $-0.36B -98.54%
2021-06-30 $0.25B $-0.13B -124.43%
2021-03-31 $0.20B $-0.21B -83.82%
2020-12-31 $0.18B $-0.20B -85.58%
2020-09-30 $0.17B $-0.26B -89.54%
2020-06-30 $0.13B $-0.30B -84.45%
2020-03-31 $0.13B $-0.11B -107.11%
2019-12-31 $0.13B $-0.08B -90.71%
2019-09-30 $0.13B $-0.12B -136.59%
2019-06-30 $0.12B $-0.16B -291.12%
2019-03-31 $0.12B $-0.19B 1394.29%
2018-12-31 $0.12B $0.11B 115.69%
2018-09-30 $0.09B $0.08B 77.51%
2018-06-30 $0.07B $0.04B 53.89%
2018-03-31 $0.04B $0.18B 27.05%
2017-12-31 $0.03B $0.15B 20.58%
2017-09-30 $0.04B $0.16B 30.82%
2017-06-30 $0.04B $0.13B 30.12%
2017-03-31 $0.05B $0.14B 38.02%
2016-12-31 $0.04B $0.13B 35.07%
2016-09-30 $0.04B $0.12B 40.80%
2016-06-30 $0.04B $0.10B 34.78%
2016-03-31 $0.04B $0.08B 31.80%
2015-12-31 $0.00B $0.11B -2.29%
2015-09-30 $-0.01B $0.15B -4.84%
2015-06-30 $-0.01B $0.14B -4.90%
2015-03-31 $-0.01B $0.13B -7.12%
2014-12-31 $0.01B $0.16B 9.40%
2014-09-30 $-0.01B $0.14B -4.61%
2014-06-30 $-0.11B $0.13B -83.17%
2014-03-31 $-0.11B $0.12B -75.64%
2013-12-31 $-0.10B $0.13B -57.14%
2013-09-30 $-0.19B $0.13B -103.90%
2013-06-30 $-0.09B $0.21B -47.85%
2013-03-31 $-0.09B $0.21B -48.79%
2012-12-31 $-0.08B $0.20B -52.01%
2012-09-30 $0.03B $0.15B 18.52%
2012-06-30 $-0.41B $0.15B -293.86%
2012-03-31 $-0.39B $0.15B -423.72%
2011-12-31 $-0.38B $0.14B -537.54%
2011-09-30 $-0.37B $0.12B -789.19%
2011-06-30 $0.08B $-0.03B 514.29%
2011-03-31 $0.09B $0.06B 472.73%
2010-12-31 $0.11B $0.04B -961.70%
2010-09-30 $0.13B $0.00B -271.58%
2010-06-30 $0.14B $-0.02B -174.39%
2010-03-31 $0.15B $-0.06B -123.73%
2009-12-31 $0.14B $-0.11B -91.12%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.149B $2.348B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.715B 19.43
Encompass Health (EHC) United States $11.983B 25.40
DaVita (DVA) United States $10.763B 15.13
Elanco Animal Health (ELAN) United States $7.311B 15.66
Chemed (CHE) United States $6.894B 21.67
Option Care Health (OPCH) United States $5.081B 22.65
RadNet (RDNT) United States $4.175B 265.00
Addus HomeCare (ADUS) United States $2.031B 22.30
LifeStance Health (LFST) United States $1.857B 0.00
Astrana Health (ASTH) United States $1.382B 34.24
U.S Physical Therapy (USPH) United States $1.226B 31.64
Pennant (PNTG) United States $0.893B 32.78
Aveanna Healthcare Holdings (AVAH) United States $0.870B 49.56
Atai Life Sciences (ATAI) Germany $0.551B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.041B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00